Advanced / metastatic Leukemia clinical trials — official public records

USClinicalTrials.gov【Trial record】

A Clinical Trial to Evaluate Efficacy, Safety, and Pharmacokinetics of Gamunex in Participants With Secondary Antibody Deficiency Associated With Chronic Lymphocytic Leukemia, Multiple Myeloma, or Non-Hodgkin Lymphoma

Phase 3RecruitingSource updated: Oct 1, 2026

Select this record

View original

USEUCNOTHERClinicalTrials.gov【Trial record】

A Long-term Extension Study of PCI-32765 (Ibrutinib)

Phase 3Active, not recruitingSource updated: Oct 1, 2026

Select this record

View original

USClinicalTrials.gov【Trial record】

A Multicenter Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-Cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymph...

Not applicableRecruitingSource updated: Oct 1, 2026

Select this record

View original

OTHERClinicalTrials.gov【Trial record】

A Study of Patient Characteristics, Co-Morbidities, and Treatment Patterns in Chronic Myeloid Leukemia Patients in Kuwait

Not yet recruitingSource updated: Oct 1, 2026

Select this record

View original

USOTHERClinicalTrials.gov【Trial record】

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

Phase 2RecruitingSource updated: Oct 1, 2026

Select this record

View original

USOTHERClinicalTrials.gov【Trial record】

A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic Leukemia

Phase 3Active, not recruitingSource updated: Oct 1, 2026

Select this record

View original

USClinicalTrials.gov【Trial record】

Acalabrutinib With or Without Obinutuzumab in Treating Patients With Early-Stage Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Phase 2RecruitingSource updated: Oct 1, 2026

Select this record

View original

USClinicalTrials.gov【Trial record】

Anti-CRLF2-R/TSLPR Chimeric Antigen Receptor T Cells (TSLPR-CART) in Participants With Recurrent or Refractory CRLF2-R/TSLPR-Overexpressing B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Phase 1RecruitingSource updated: Oct 1, 2026

Select this record

View original

USOTHERClinicalTrials.gov【Trial record】

Assessing the Ability of Combination Treatment With Venetoclax to Permit Time Limited Therapy in Chronic Lymphocytic Leukemia

Phase 3Active, not recruitingSource updated: Oct 1, 2026

Select this record

View original

USClinicalTrials.gov【Trial record】

Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies

Phase 1RecruitingSource updated: Oct 1, 2026

Select this record

View original

USClinicalTrials.gov【Trial record】

Blinatumomab Consolidation in Real World

RecruitingSource updated: Oct 1, 2026

Select this record

View original

USEUClinicalTrials.gov【Trial record】

Bosutinib in Pediatric Patients With Newly Diagnosed Chronic Phase or Resistant/Intolerant Ph + Chronic Myeloid Leukemia

Phase 1/2Active, not recruitingSource updated: Oct 1, 2026

Select this record

View original

OTHERClinicalTrials.gov【Trial record】

Cardiotoxicity in Newly Diagnosed Acute Myeloid Leukemia Patients

Not yet recruitingSource updated: Oct 1, 2026

Select this record

View original

USOTHERClinicalTrials.gov【Trial record】

Inotuzumab Ozogamicin in Treating Younger Patients With B-Lymphoblastic Lymphoma or Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia

Phase 2Active, not recruitingSource updated: Oct 1, 2026

Select this record

View original

USClinicalTrials.gov【Trial record】

Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia

Phase 3Active, not recruitingSource updated: Oct 1, 2026

Select this record

View original

USClinicalTrials.gov【Trial record】

Lisocabtagene Maraleucel, Nivolumab and Ibrutinib for the Treatment of Richter's Transformation

Phase 2Active, not recruitingSource updated: Oct 1, 2026

Select this record

View original

USClinicalTrials.gov【Trial record】

Natural History Study of Early Life Exposures in Agriculture (ELEA)

Enrolling by invitationSource updated: Oct 1, 2026

Select this record

View original

USClinicalTrials.gov【Trial record】

Nemtabrutinib for Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Leukemia (SLL) Refractory to Covalent Bruton Tyrosine Kinase Inhibitor or Pirtobrutinib and Previously Treated With a BCL2 Inhibitor

Phase 2Not yet recruitingSource updated: Oct 1, 2026

Select this record

View original

USClinicalTrials.gov【Trial record】

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

RecruitingSource updated: Oct 1, 2026

Select this record

View original

USClinicalTrials.gov【Trial record】

Phase II Study Assessing the Efficacy and Toxicity of Olverembatinib Monotherapy in Patients With Chronic Myeloid Leukemia in Chronic Phase After Failing One Prior Therapy With a Second Generation Tyrosine Kinase Inhibitor or Asciminib

Phase 2RecruitingSource updated: Oct 1, 2026

Select this record

View original

EUClinicalTrials.gov【Trial record】

Phenotypic and Functional Characterization of Bone Marrow Macrophages in Chronic Myelomonocytic Leukemia

Not applicableNot yet recruitingSource updated: Oct 1, 2026

Select this record

View original

OTHERClinicalTrials.gov【Trial record】

Preliminary Assessment of [18F]BL40 in PET/CT Scans

RecruitingSource updated: Oct 1, 2026

Select this record

View original

USOTHERClinicalTrials.gov【Trial record】

Rituximab and Bendamustine Hydrochloride, Rituximab and Ibrutinib, or Ibrutinib Alone in Treating Older Patients With Previously Untreated Chronic Lymphocytic Leukemia

Phase 3Active, not recruitingSource updated: Oct 1, 2026

Select this record

View original

USClinicalTrials.gov【Trial record】

Rutgers University Study of the Genetics of Blood Cancers

RecruitingSource updated: Oct 1, 2026

Select this record

View original

USClinicalTrials.gov【Trial record】

Ruxolitinib for the Treatment of T-Cell Large Granular Lymphocytic Leukemia

Phase 2RecruitingSource updated: Oct 1, 2026

Select this record

View original

USClinicalTrials.gov【Trial record】

Stem Cell Transplantation for Participants With Germline RUNX1 Associated Blood Cancers

Phase 2Not yet recruitingSource updated: Oct 1, 2026

Select this record

View original

USClinicalTrials.gov【Trial record】

Tafasitamab and Zanubrutinib for the Treatment of Patients With Newly Diagnosed Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma, TaZA CLL Study

Phase 2Active, not recruitingSource updated: Oct 1, 2026

Select this record

View original

USOTHERClinicalTrials.gov【Trial record】

Testing the Addition of Venetoclax or Gemtuzumab Ozogamicin (GO) to Usual Treatment Regimen (Cytarabine and Daunorubicin, "7+3") for Core Binding Factor Acute Myeloid Leukemia (CBF-AML) to Improve Response (A MYELOMATCH Treatment Trial)

Phase 2RecruitingSource updated: Oct 1, 2026

Select this record

View original

USClinicalTrials.gov【Trial record】

Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes

Phase 1RecruitingSource updated: Oct 1, 2026

Select this record

View original

OTHERClinicalTrials.gov【Trial record】

Testing the Use of Combination Therapy in Patients With Persistent Low Level Acute Myeloid Leukemia Following Initial Treatment, The ERASE Study (A MyeloMATCH Treatment Trial)

Phase 2Not yet recruitingSource updated: Oct 1, 2026

Select this record

View original

USEUOTHERClinicalTrials.gov【Trial record】

A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma

Phase 3RecruitingSource updated: Sep 30, 2026

Select this record

View original

USClinicalTrials.gov【Trial record】

Automated Total Marrow and Lymphoid Irradiation for Allogeneic Hematopoietic Cell Transplant

Phase 2Not yet recruitingSource updated: Sep 30, 2026

Select this record

View original

USClinicalTrials.gov【Trial record】

CD19/CD22 Bicistronic Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory B Cell Malignancies

Phase 1/2RecruitingSource updated: Sep 30, 2026

Select this record

View original

USClinicalTrials.gov【Trial record】

CD22 CAR T-cells to Extend Remission Following Commercial CD19 CAR T-cells in Children, Adolescents, and Adults With Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia

Phase 2RecruitingSource updated: Sep 30, 2026

Select this record

View original

CNClinicalTrials.gov【Trial record】

CLL-1-Targeted In Vivo CAR-T Cell Immunotherapy for Relapsed/Refractory Acute Myeloid Leukemia

Phase 1Not yet recruitingSource updated: Sep 30, 2026

Select this record

View original

USOTHERClinicalTrials.gov【Trial record】

Comparing Different Treatment Lengths for Venetoclax in Older People With Newly Diagnosed Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)

Phase 2RecruitingSource updated: Sep 30, 2026

Select this record

View original

EUClinicalTrials.gov【Trial record】

Study for Characterisation of Predictive Parameters of Clonal Evolution in Subjects With GATA2 Germline Mutation

Not applicableRecruitingSource updated: Sep 30, 2026

Select this record

View original

USOTHERClinicalTrials.gov【Trial record】

Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study

Phase 3RecruitingSource updated: Sep 30, 2026

Select this record

View original

OTHERClinicalTrials.gov【Trial record】

Use of Electrical Bioimpedance in Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) Patients (Bioimpedance)

Not yet recruitingSource updated: Sep 30, 2026

Select this record

View original

USClinicalTrials.gov【Trial record】

Venetoclax-Obinutuzumab +/- Acalabrutinib in R/R CLL

Phase 2Active, not recruitingSource updated: Sep 30, 2026

Select this record

View original

USClinicalTrials.gov【Trial record】

A Phase 1b/2 Open-label, Dose-ranging Safety and Efficacy Study of Oral Cladribine in Patients With Acute Myeloid Leukemia (AML)

Phase 1/2Not yet recruitingSource updated: Aug 14, 2026

Select this record

View original

USClinicalTrials.gov【Trial record】

A Study to Assess Adverse Events and Change in Disease Activity When Intravenous (IV) Pivekimab Sunirine is Given in Combination With Oral Venetoclax and IV or Subcutaneous Azacitidine in Adult Participants With Acute Myeloid Leukemia (AML)

Phase 2/3RecruitingSource updated: Aug 14, 2026

Select this record

View original

USClinicalTrials.gov【Trial record】

A Study to Assess Adverse Events and How Intravenous (IV) Pivekimab Sunirine Moves Through the Body in Pediatric Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)

Phase 1RecruitingSource updated: Aug 14, 2026

Select this record

View original

USClinicalTrials.gov【Trial record】

Acalabrutinib Monotherapy vs Investigator's Choice of Treatment in Patients With CL Leukaemia and Heart Failure

Phase 4RecruitingSource updated: Aug 14, 2026

Select this record

View original

EUClinicalTrials.gov【Trial record】

IMPACT-AML: A Randomized Pragmatic Clinical Trial for Relapsed or Refractory Acute Myeloid Leukemia.

Phase 3RecruitingSource updated: Aug 14, 2026

Select this record

View original

EUClinicalTrials.gov【Trial record】

Master Framework For Relapse or Refractory Acute Myeloid Leukemia

RecruitingSource updated: Aug 14, 2026

Select this record

View original

USClinicalTrials.gov【Trial record】

Multi-institutional Prospective Research of Expanded Multi-antigen Specifically Oriented Lymphocytes for the Treatment of VEry High Risk Hematopoietic Malignancies

Phase 1RecruitingSource updated: Aug 14, 2026

Select this record

View original

USClinicalTrials.gov【Trial record】

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Phase 2RecruitingSource updated: Aug 14, 2026

Select this record

View original

USClinicalTrials.gov【Trial record】

Natural History Study of GATA2 Deficiency and Related Disorders

RecruitingSource updated: Aug 14, 2026

Select this record

View original

CNClinicalTrials.gov【Trial record】

PBSS1113 in Combination With Azacitidine to Treat Patients With AML/MDS

Phase 1/2RecruitingSource updated: Aug 14, 2026

Select this record

View original

USClinicalTrials.gov【Trial record】

Phase II Study Assessing Efficacy and Safety of Asciminib in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase.

Phase 2RecruitingSource updated: Aug 14, 2026

Select this record

View original

EUClinicalTrials.gov【Trial record】

Study of the Use of Venetoclax in Participants With Chronic Lymphocytic Leukemia (CLL) Under Real-Life Setting

RecruitingSource updated: Aug 14, 2026

Select this record

View original

OTHERClinicalTrials.gov【Trial record】

Study to Assess Adverse Events and Change in Disease Activity of Oral Venetoclax in Combination With Subcutaneous (SC) or Intravenous (IV) Azacitidine in Newly Diagnosed Adult Participants With Acute Myeloid Leukemia (AML) Who Are Ineligible for Standard Induction Therapy in India

Phase 4RecruitingSource updated: Aug 14, 2026

Select this record

View original

USClinicalTrials.gov【Trial record】

Dose-Adjusted EPOCH With or Without Rituximab Plus Ponatinib for the Treatment of Newly-Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia/Lymphoma

Phase 2RecruitingSource updated: Aug 13, 2026

Select this record

View original

USClinicalTrials.gov【Trial record】

Evaluation of Pediatric eCART Implementation

Not applicableRecruitingSource updated: Aug 13, 2026

Select this record

View original

USClinicalTrials.gov【Trial record】

Fractionated Gemtuzumab Ozogamicin in Treating Measurable Residual Disease in Patients With Acute Myeloid Leukemia

Phase 2RecruitingSource updated: Aug 13, 2026

Select this record

View original

USClinicalTrials.gov【Trial record】

Pathogenesis of Hematologic Malignancies

Enrolling by invitationSource updated: Aug 13, 2026

Select this record

View original

EUClinicalTrials.gov【Trial record】

Quantification of Peripheral Blood iNKTs After Allogeneic Stem Cell Transplantation

RecruitingSource updated: Aug 13, 2026

Select this record

View original

USClinicalTrials.gov【Trial record】

Real World Asparaginase Therapy Toxicity

Not yet recruitingSource updated: Aug 13, 2026

Select this record

View original

USClinicalTrials.gov【Trial record】

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

Phase 2RecruitingSource updated: Aug 13, 2026

Select this record

View original

USClinicalTrials.gov【Trial record】

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

Phase 2RecruitingSource updated: Aug 13, 2026

Select this record

View original

CNCDE【Guideline / public regulatory information】

CDE 临床试验默示许可 — clinical trial implied licence notices

Index verified: Aug 16, 2026

Select this record

View original

CNCDE【Guideline / public regulatory information】

CDE 优先审评公示 — priority review listings

Index verified: Aug 16, 2026

Select this record

View original

CNCDE【Guideline / public regulatory information】

CDE 受理品种信息 — applications accepted for review

Index verified: Aug 16, 2026

Select this record

View original

CNCDE【Guideline / public regulatory information】

CDE 指导原则 — published technical guidance documents

Index verified: Aug 16, 2026

Select this record

View original

CNCDE【Guideline / public regulatory information】

CDE 突破性治疗公示 — breakthrough therapy designation notices

Index verified: Aug 16, 2026

Select this record

View original

CNCDE【Guideline / public regulatory information】

CDE 附条件批准品种 — conditionally approved products list

Index verified: Aug 16, 2026

Select this record

View original

CNChiCTR【Guideline / public regulatory information】

ChiCTR — Chinese Clinical Trial Registry, public search

Index verified: Aug 16, 2026

Select this record

View original

EUCTIS【Guideline / public regulatory information】

CTIS public register — search clinical trials authorised in the EU/EEA

Index verified: Aug 16, 2026

Select this record

View original

EUEMA【Guideline / public regulatory information】

EMA — CHMP meeting highlights and opinions on new medicines

Index verified: Aug 16, 2026

Select this record

View original

EUEMA【Guideline / public regulatory information】

EMA — medicines for human use currently under evaluation (monthly CHMP list)

Index verified: Aug 16, 2026

Select this record

View original

EUEMA【Guideline / public regulatory information】

EMA — searchable database of authorised medicines in the EU

Index verified: Aug 16, 2026

Select this record

View original

EUESMO【Guideline / public regulatory information】

ESMO Clinical Practice Guidelines — public index by tumour type

Index verified: Aug 16, 2026

Select this record

View original

EUESMO【Guideline / public regulatory information】

ESMO Clinical Practice Guidelines — supportive and palliative care section

Index verified: Aug 16, 2026

Select this record

View original

USFDA【Guideline / public regulatory information】

FDA — expanded access (compassionate use) information for patients

Index verified: Aug 16, 2026

Select this record

View original

USFDA【Guideline / public regulatory information】

FDA — oncology (cancer) / hematologic malignancies approval notifications

Index verified: Aug 16, 2026

Select this record

View original

USFDA【Guideline / public regulatory information】

FDA — ongoing accelerated approvals for oncology indications

Index verified: Aug 16, 2026

Select this record

View original

USNCCN【Guideline / public regulatory information】

NCCN Guidelines — palliative care category listing

Index verified: Aug 16, 2026

Select this record

View original

USNCCN【Guideline / public regulatory information】

NCCN Guidelines — public index by cancer type (free registration)

Index verified: Aug 16, 2026

Select this record

View original

USNCCN【Guideline / public regulatory information】

NCCN Guidelines for Patients — plain-language versions

Index verified: Aug 16, 2026

Select this record

View original

CNNMPA【Guideline / public regulatory information】

NMPA 药品 — national drug approval announcements

Index verified: Aug 16, 2026

Select this record

View original

CNCDE【Guideline / public regulatory information】

药物临床试验登记与信息公示平台 — national registry of drug trials conducted in China

Index verified: Aug 16, 2026

Select this record

View original